|
OLMA Olema Pharmaceuticals Inc 1750284 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-63,200,000.00 |
| Balance Sheet |
|
Current Assets
|
$469,876,000.00 |
|
Assets
|
$486,578,000.00 |
|
Current Liabilities
|
$53,014,000.00 |
|
Liabilities
|
$56,014,000.00 |
|
Equity
|
$430,564,000.00 |
|
Shares Out
|
87452166.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-91,883,000.00 |
|
Investing Cash Flow
|
$45,370,000.00 |
| Market Analysis |
Market Cap
|
$953,228,609.40 |
|
Price
|
$10.90 |
|
BVPS
|
4.92 |
|
PB
|
2.22 |
|
EPS
|
-0.61 |
|
FCF
|
$-92,104,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:36 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:27 |
|
| Apr |
May |
Jun |
| 2026-03-16 |
-0.50 |
|
|
2026-05-12 |
-0.52 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.51 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.49 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view OLMA documents filed with the SEC.
OLMA Filings
Clear
